Healthcare provider profile · identity verified

Michael Harris, CFNP

Nurse Practitioner · SILVER CITY, NM · NPI 1497198808

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	314	91
Levothyroxine Sodium	Levothyroxine Sodium	311	91
Atorvastatin Calcium	Atorvastatin Calcium	294	81
Metformin Hcl	Metformin Hcl	270	78
Oxycodone Hcl	Oxycodone Hcl	267	30
Gabapentin	Gabapentin	233	63
Amlodipine Besylate	Amlodipine Besylate	218	57
Losartan Potassium	Losartan Potassium	204	54
Meloxicam	Meloxicam	164	51
Alprazolam	Alprazolam	153	26
Albuterol Sulfate Hfa	Albuterol Sulfate	142	52
Trazodone Hcl	Trazodone Hcl	139	38
Potassium Chloride	Potassium Chloride	137	42
Prednisone	Prednisone	136	68
Omeprazole	Omeprazole	128	36
Tamsulosin Hcl	Tamsulosin Hcl	128	37
Pregabalin	Pregabalin	127	30
Morphine Sulfate Er	Morphine Sulfate	124	12
Simvastatin	Simvastatin	118	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	114	28
Lorazepam	Lorazepam	114	27
Ozempic	Semaglutide	114	17
Metoprolol Succinate	Metoprolol Succinate	108	32
Tramadol Hcl	Tramadol Hcl	108	26
Fluticasone Propionate	Fluticasone Propionate	106	37
Hydrochlorothiazide	Hydrochlorothiazide	105	32
Zolpidem Tartrate	Zolpidem Tartrate	103	18
Duloxetine Hcl	Duloxetine Hcl	98	18
Hydromorphone Hcl	Hydromorphone Hcl	96	12
Furosemide	Furosemide	91	31
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	90	13
Famotidine	Famotidine	88	31
Pantoprazole Sodium	Pantoprazole Sodium	85	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	83	23
Eliquis	Apixaban	79	20
Sertraline Hcl	Sertraline Hcl	79	20
Quetiapine Fumarate	Quetiapine Fumarate	75	15
Ibuprofen	Ibuprofen	73	30
Tizanidine Hcl	Tizanidine Hcl	71	24
Citalopram Hbr	Citalopram Hydrobromide	70	23
Diazepam	Diazepam	70	suppressed
Pravastatin Sodium	Pravastatin Sodium	66	20
Venlafaxine Hcl Er	Venlafaxine Hcl	65	12
Glipizide	Glipizide	64	19
Temazepam	Temazepam	60	suppressed
Azelastine Hcl	Azelastine Hcl	59	23
Ondansetron Odt	Ondansetron	59	20
Ropinirole Hcl	Ropinirole Hcl	58	16
Clonazepam	Clonazepam	57	17
Montelukast Sodium	Montelukast Sodium	54	17
Allopurinol	Allopurinol	51	14
Amitriptyline Hcl	Amitriptyline Hcl	50	15
Cephalexin	Cephalexin	49	29
Bupropion Xl	Bupropion Hcl	47	15
Warfarin Sodium	Warfarin Sodium	47	13
Celecoxib	Celecoxib	46	12
Escitalopram Oxalate	Escitalopram Oxalate	45	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	45	11
Rosuvastatin Calcium	Rosuvastatin Calcium	45	14
Estradiol	Estradiol	44	13
Clopidogrel	Clopidogrel Bisulfate	43	15
Farxiga	Dapagliflozin Propanediol	43	suppressed
Carvedilol	Carvedilol	41	13
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	40	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	39	suppressed
Tresiba Flextouch U-100	Insulin Degludec	38	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	31
Prazosin Hcl	Prazosin Hcl	37	suppressed
Humulin R	Insulin Regular, Human	36	suppressed
Terazosin Hcl	Terazosin Hcl	36	suppressed
Trulicity	Dulaglutide	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Dexamethasone	Dexamethasone	28	17
Lidocaine	Lidocaine	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	21
Clonidine Hcl	Clonidine Hcl	27	suppressed
Jardiance	Empagliflozin	27	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	16
Methimazole	Methimazole	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Methotrexate	Methotrexate Sodium	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Azithromycin	Azithromycin	24	17
Breyna	Budesonide/Formoterol Fumarate	24	suppressed
Morphine Sulfate	Morphine Sulfate	24	suppressed
Nystatin	Nystatin	24	suppressed
Primidone	Primidone	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	11
Methocarbamol	Methocarbamol	23	suppressed
Naproxen	Naproxen	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Arnuity Ellipta	Fluticasone Furoate	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Baclofen	Baclofen	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Gemfibrozil	Gemfibrozil	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Testosterone Cypionate	Testosterone Cypionate	21	suppressed
Atenolol	Atenolol	20	suppressed
Finasteride	Finasteride	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Bumetanide	Bumetanide	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Methadone Hcl	Methadone Hcl	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Levofloxacin	Levofloxacin	16	14
Lovastatin	Lovastatin	16	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Mupirocin	Mupirocin	15	12
Nitroglycerin	Nitroglycerin	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Scopolamine	Scopolamine	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Topiramate	Topiramate	15	suppressed
Prolia	Denosumab	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Cefdinir	Cefdinir	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error